SA
GMAB icon

Sanctuary Advisors’s Genmab GMAB Stock Holding History

Sanctuary Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Sell
8,619
-2,231
-21% -$59.3K ﹤0.01% 2494
2026
Q1 		$291K Sell
10,850
-57,908
-84% -$1.74M ﹤0.01% 2119
2025
Q4 		$2.12M Buy
68,758
+10,843
+19% +$338K 0.01% 903
2025
Q3 		$1.78M Buy
+57,915
New +$1.41M 0.01% 967
2025
Q1 		– Sell
-11,091
Closed -$220K – 2286
2024
Q4 		$220K Sell
11,091
-21,709
-66% -$477K ﹤0.01% 2198
2024
Q3 		$677K Sell
32,800
-21,093
-39% -$564K ﹤0.01% 1509
2024
Q2 		$1.52M Buy
+53,893
New +$1.53M 0.01% 959

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Sanctuary Advisors's GMAB Position: Q2 2026 in Review

Sanctuary Advisors reduced its Genmab (GMAB) stake by 21% in Q2 2026, selling an estimated $59.3K and leaving 8,619 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #2494.

Sanctuary Advisors first reported a position in GMAB in Q2 2024 and has held it in 7 quarters since. The position peaked at $2.12M in Q4 2025. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Sanctuary Advisors held 8,619 shares of Genmab worth $237K as of Q2 2026.
  • Sanctuary Advisors sold 2,231 Genmab shares in Q2 2026, an estimated $59.3K.
  • Genmab made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #2494 holding.
  • Sanctuary Advisors first reported a position in Genmab in Q2 2024 and has held it in 7 quarters since.
  • Sanctuary Advisors's Genmab position peaked at $2.12M in Q4 2025.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.